A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy

por Bryant, Kelly G., Chae, Young Chan, Martinez, Rogelio L., Gordon, John C., Elokely, Khaled M., Kossenkov, Andrew V., Grant, Steven, Childers, Wayne E., Abou-Gharbia, Magid, Altieri, Dario C.
Publicado 2017